The illicit market of controlled drugs in Italy: New drugs and trends;Il mercato illecito delle sostanze stupefacenti in Italia: Nuove droghe e trend di sviluppo

Annali dell'Istituto Superiore di Sanita

Volumn 38, Issue 3, 2002, Pages 315-318

  Schiavone, Sergio ^a  

^a NONE

Author keywords

2 C B; 2 C T 7; 4 MTA; Controlled drugs; GBL; GHB; Illicit market; Internet; Ketamine; MBDB; MDMA

Indexed keywords

2,5 DIMETHOXY 4 PROPYLTHIOPHENETHYLAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3,4 METHYLENEDIOXYPHENYL N METHYL 2 BUTANAMINE; 4 HYDROXYBUTYRIC ACID; 4 METHYLTHIOAMPHETAMINE; AMPHETAMINE DERIVATIVE; BROLAMFETAMINE; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; KETAMINE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG ABUSE; DRUG CONTROL; DRUG EFFECT; DRUG TRAFFIC; INTERNET; ITALY; PURCHASING; SEIZURE;

EID: 0036958669     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. European Monitoring Centre for Drugs and Drug Addiction. Annual Report on the state of the drugs problem in the European Union 2000. Bruxelles: European Union; 2000.
2. Europol. European Union situation report on drug production and drug trafficking 1999/2000. The Hague: Europol; 2000.
3. Direzione Centrale per i Servizi Antidroga. Relazione annuale 2000 della Direzione Centrale per i Servizi Antidroga del Dipartimento della Pubblica Sicurezza. Roma: DCSA; 2000.
4. Shulgin Al, Shulgin An. Phenethylamines I have known and loved. A chemical love story. Berkeley: Transform Press; 1991.
5. Hardman HF et al. Relationship of the structure of mescaline and seven analogs to toxicity and bahavior in five species of laboratory animals. Toxicol Appl Pharmacol 1973;25:299-309.
6. Green AR, Goodwin GM. Ecstasy and neurodegeneration: ecstasy's long term effect are potentially more damaging than its acute toxicity. Br J Med 1996;312:1493.
7. Schifano F. Dangerous driving and MDMA (ecstasy) abuse. J Serotonin Res 1995;1:53-7.
8. Parrot AC, Lasky J, Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 1998;139(3):261-8.
9. McCann UD, Mertl M, Eligulashvili V, Ricuarte GA. Cognitive performance in 3,4 methylendioxymethamphetamine (MDMA, ecstasy) users: a controlled study. Psychopharmacology 1999;143(4):417-25.
10. Nichols DE, Hoffman AJ, Oberlender P Jacob III, Shulgin AT. Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamines: representatives of a novel therapeutic class. J Med Chem 1986;29:2009-15.
11. Nichols DE. Differences between the mechanism of MDMA, MBDB and the classical hallucinogens; identification of a new therapeutic class: entactogens. J Psychoact Drugs 1986;18(4):305-13.
12. Giroud C, Augsburger M, Rivier L, Mngin P, Sadeghipour F, Varesio E, Veuthey JL, Kamalaprija P. 2C-B: a new psychoactive phenylethylamine recently discovered in ecstasy tablets sold on the Swiss black market. J Anal Toxicol 1998;22(5):345-54.
13. De Boer D, Gijzels MJ, Bosman IJ, Maes RAA. More data about the new psychoactive drug 2C-B. J Anal Toxicol 1999;23(3):227-8.
14. Mamelak M, Escriu J, Stokan O. The effects of gamma-hydroxybutyrate on sleep. Biologic Psychiatr 1977;12(2):273-88.
15. Fieler EL, Coleman DE, Baselt RC. Gamma-hydroxybutyrate concentrations in pre- and postmortem blood and urine. Clin Chem 1997;44:692.
16. Ropero-Miller JD, Goldberger BA. Recreational drugs; current trends in the 90s. Toxicology 1998;18(4):727-46.
17. Cunningham BL, McKinney P. Patient acceptance of dissociative anesthetics. Plastic reconstr surg 1983;72(1):22-6.
18. Lindefors N, Barati S, O'Connor WT. Effects of ketamine administration on dopamine, serotonin and GABA transmission. Brain Res 1997;759(2):205-12.
19. Folda F. La droga si vende on line. Panorama 2001;39(40):99-100.
20. Valdes LJ, Jose LD, Paul AG. Ethnopharmacology of ska Maria Pastora (Salvia divinorum, Epling and Jativam). J Ethnopharmacol 1983;7:287-312.
21. Valdes LJ, Butler WM, Hatfield GM, Paul AG, Koreeda M. Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum. J Organic Chem 1984;49:4716.
22. Valdes LJ. Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. J Psychoact Drugs 1994;26(3):277-83.
23. Siebert DJ. Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 1994;43:53-6.